A detailed history of Platform Technology Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Platform Technology Partners holds 2,091 shares of LLY stock, worth $1.91 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
2,091
Previous 2,151 2.79%
Holding current value
$1.91 Million
Previous $1.16 Million 5.45%
% of portfolio
0.5%
Previous 0.55%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $31,511 - $37,147
-60 Reduced 2.79%
2,091 $1.22 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $27,386 - $37,755
63 Added 3.02%
2,151 $1.16 Million
Q2 2023

Jul 12, 2023

BUY
$350.74 - $468.98 $15,783 - $21,104
45 Added 2.2%
2,088 $979,000
Q1 2023

Apr 04, 2023

BUY
$310.63 - $364.82 $56,845 - $66,762
183 Added 9.84%
2,043 $701,000
Q4 2022

Jan 11, 2023

BUY
$321.55 - $374.67 $9,324 - $10,865
29 Added 1.58%
1,860 $0
Q3 2022

Oct 24, 2022

BUY
$296.48 - $337.87 $1,482 - $1,689
5 Added 0.27%
1,831 $592,000
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $278 - $327
1 Added 0.05%
1,826 $592,000
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $19,713 - $24,499
-84 Reduced 4.4%
1,825 $523,000
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $11,917 - $14,789
-53 Reduced 2.7%
1,909 $527,000
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $588,348 - $724,045
-2,655 Reduced 57.5%
1,962 $453,000
Q2 2021

Aug 05, 2021

BUY
$180.55 - $233.54 $157,620 - $203,880
873 Added 23.32%
4,617 $1.06 Million
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $3,783 - $5,006
29 Added 0.78%
3,744 $632,000
Q3 2020

Nov 30, 2020

BUY
$146.22 - $169.13 $10,966 - $12,684
75 Added 2.06%
3,715 $550,000
Q2 2020

Nov 30, 2020

SELL
$136.42 - $164.18 $3,137 - $3,776
-23 Reduced 0.63%
3,640 $598,000
Q1 2020

Nov 30, 2020

BUY
$119.05 - $147.35 $436,080 - $539,743
3,663 New
3,663 $508,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.